Risk aversion and COVID‐19 vaccine hesitancy

Anthony Lepinteur, Liyousew Borga, Andrew Clark, Claus Vögele and Conchita D’Ambrosio

Health Economics, 2023, vol. 32, issue 8, 1659-1669

Abstract: We here investigate the role of risk aversion in COVID‐19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID‐19 infection and vaccination side‐effects involve probabilistic elements. In large‐scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID‐19 infection is perceived as involving greater risk than is vaccination.

Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1002/hec.4693

Related works:
Working Paper: Risk aversion and COVID‐19 vaccine hesitancy (2023)
Working Paper: Risk aversion and COVID‐19 vaccine hesitancy (2023)
Working Paper: Risk Aversion and COVID-19 Vaccine Hesitancy (2023)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:32:y:2023:i:8:p:1659-1669

Access Statistics for this article

Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().